Case Report of a Challenging Diagnosis of Nasal Tuberculosis

Autor: Joana Ida Dias, Ana Nóbrega Pinto, Francisco Sousa Vieira, Luís Meireles

Publikováno v: Acta Médica Portuguesa (2023)

N/a.

Externí odkaz: https://doaj.org/article/3b2176cad056485ca9acca53867ffbc9

Availability and costs of medicines for the treatment of tuberculosis in Europe

Autor: Günther, Gunar, Guglielmetti, Lorenzo, Leu, Claude, Lange, Christoph, van Leth, Frank, Hafizi, Hasan, Khachatryan, Naira, Aroyan, Harut, Kabasakalyan, Eduard, Knappik, Michael, Skrahina, Alena, Klimuk, Dzmitry, Nikolenka, Alena, Muylle, Inge, Milanov, Vladimir, Velkovska, Desislava, Tarinska, Neli, Bachiyska, Elizabeta, Jankovic, Mateja, Pieridou, Despo, Adamide, Tonia, Nicolaou, Nicos, Vasakova, Martina, Sukholytka, Mariia, Kopeckà, Emilia, Andersen, Åse Bengård, Folkvardsen, Dorte Bek, Svensson, Erik, Danilovits, Manfred, Kummik, Tiina, Vasankari, Tuula, Fréchet-Jachym, Mathilde, Nahmiash, Audrey, Togonidze, Tamar, Avaliani, Zaza, Kinkladze, Inga, Aspindzelashvili, Rusudan, Bichashvili, Teona, Losaberidze, Gulnazi, Merabishvili, Tsitsino, Kalsdorf, Barbara, Manika, Katerina, Tsiakitzis, Karyofyllis, Bakos, Agnes, Ægisdóttir, Tinna Rán, Michelsen, Guðrún Svanhvít, Karlsdóttir, Kristín, McLaughlin, Anne-Marie, Fitzgibbon, Margaret, Chemtob, Daniel, Codecasa, Luigi R., Ferrarese, Maurizio, Torri, Stefania, Gjocaj, Majlinda, Kuksa, Liga, Davidaviciene, Edita, Wirtz, Gil, Perrin, Monique, Asciak, Analita Pace, Chesov, Dumitri, de Lange, Wiel, Akkerman, Onno, Poposka, Biljana Ilievska, Mack, Ulrich, Jensenius, Mogens, Kvalvik, Lajla, Mengshoel, Anne Torunn, Kruczak, Katarzyna, Duarte, Raquel, Ribeiro, Nadine, Ibraim, Elmira, Kaluzhenina, Anna, Barkanova, Olga, Pesut, Dragica, Solovic, Ivan, Svetina, Petra, Souza-Galvão, Maria-Luiza de, Millet, Joan-Pau, Casas, Xavi, Vives, Montserrat, Bruchfeld, Judith, Dalemo, Paulina, Jonsson, Jerker, Aeschbacher, Katrin, Keller, Peter, Özkara, Seref, Tiberi, Simon, Chen, Christabelle, Terleeva, Yana, Dudnyk, Andrii

Publikováno v: Günther, Gunar; Guglielmetti, Lorenzo; Leu, Claude; Lange, Christoph; van Leth, Frank (2023). Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical microbiology and infection, 29(1), pp. 77-84. Elsevier 10.1016/j.cmi.2022.07.026
Clinical Microbiology and Infection, 29(1), 77-84. Elsevier
Clinical Microbiology and Infection (CMI)
Clinical Microbiology and Infection, 29(1), 77-84. ELSEVIER SCI LTD
Tuberculosis Network European Trials group 2023, ' Availability and costs of medicines for the treatment of tuberculosis in Europe ', Clinical Microbiology and Infection, vol. 29, no. 1, pp. 77-84 . https://doi.org/10.1016/j.cmi.2022.07.026
Clinical microbiology and infection, vol. 28, pp. 1-29, 2022.

Objectives: To evaluate the access to comprehensive diagnostics and novel antituberculosis medicines in European countries.Methods: We investigated the access to genotypic and phenotypic Mycobacterium tuberculosis drug susceptibility testing and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e493f81f90e0427ac6847c07be1da989
https://doi.org/10.1016/j.cmi.2022.07.026

Rifapentine access in Europe:growing concerns over key tuberculosis treatment component

Autor: Lorenzo Guglielmetti, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia-Basteiro, Delia Goletti, Mateja Jankovic, Liga Kuksa, Florian P. Maurer, Frédéric Méchaï, Simon Tiberi, Frank van Leth, Nicolas Veziris, Christoph Lange

Publikováno v: Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) & Tuberculosis Network European Trials group (TBnet) 2022, ' Rifapentine access in Europe : growing concerns over key tuberculosis treatment component ', European Respiratory Journal, vol. 59, no. 5, 2200388, pp. 1-3 . https://doi.org/10.1183/13993003.00388-2022
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2022, 59 (5), pp.2200388. ⟨10.1183/13993003.00388-2022⟩
European Respiratory Journal, 59(5):2200388, 1-3. European Respiratory Society

International audience; Rifapentine, a synthetic derivate of rifampicin which was developed in 1965, has interesting pharmacological properties, including a long terminal half-life (13 h, compared to 2-3 h for rifampicin) and promising bactericidal a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86ddc6a96141b50eb8c5615420c5f7b
https://hdl.handle.net/1871.1/d90bdc8a-e243-4590-968b-48797208699a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tobacco smoking impact on tuberculosis treatment outcome: an observational study from West Africa

Autor: Julie Glerup Bay, Cecilie Blenstrup Patsche, Nicoline Marie Svendsen, Victor Francesco Gomes, Frauke Rudolf, Christian Wejse

Publikováno v: Bay, J G, Patsche, C B, Svendsen, N M, Gomes, V F, Rudolf, F & Wejse, C 2022, ' Tobacco smoking impact on tuberculosis treatment outcome : an observational study from West Africa ', International Journal of Infectious Diseases, vol. 124, no. Suppl. 1, pp. S50-S55 . https://doi.org/10.1016/j.ijid.2022.07.067

OBJECTIVE: Both tuberculosis (TB) and tobacco smoking are preventable health hazards. Few studies have examined the relationship between TB and tobacco smoking in an African setting, where the two health burdens collide heavily. This study aimed to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e37dc99fdbbd8706a46c3ba799489150
https://pubmed.ncbi.nlm.nih.gov/35914683